{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:49:54Z","timestamp":1771030194439,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T00:00:00Z","timestamp":1487721600000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002736","name":"Covidien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jcin.2015.10.049","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T16:50:13Z","timestamp":1453308613000},"page":"331-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in\u00a0Acute Coronary Syndromes?"],"prefix":"10.1016","volume":"9","author":[{"given":"Jeffrey D.","family":"Wessler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"G\u00e9n\u00e9reux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girma Minalu","family":"Ayele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin J.","family":"Brener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"McEntegart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ori","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay J.","family":"Kirtane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2015.10.049_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijcard.2010.05.006","article-title":"Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina","volume":"151","author":"Bauer","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2015.10.049_bib2","first-page":"960","article-title":"Visible angiographic complications predict short and long-term outcomes in patients with post-procedural creatine-phosphokinase elevation","volume":"76","author":"Fefer","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2015.10.049_bib3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2015.10.049_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/eurheartj\/ehp033","article-title":"Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"30","author":"Fokkema","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2015.10.049_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjcard.2013.08.034","volume":"113","author":"Kirtane","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2015.10.049_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jacc.2013.10.022","volume":"63","author":"Genereux","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2015.10.049_bib7","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.jacc.2012.02.019","volume":"59","author":"McEntegart","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2015.10.049_bib8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjcard.2006.08.054","article-title":"Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality","volume":"99","author":"Brosh","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2015.10.049_bib9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1053\/euhj.2001.3035","article-title":"Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction","volume":"23","author":"Henriques","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2015.10.049_bib10","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.jacc.2003.07.012","article-title":"Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"42","author":"Mehta","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2015.10.049_bib11","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2009.12.054","article-title":"5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction","volume":"55","author":"Ndrepepa","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2015.10.049_bib12","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2169\/internalmedicine.47.0884","article-title":"Predictors and long-term prognostic implications of angiographic slow\/no-flow during percutaneous coronary intervention for acute myocardial infarction","volume":"47","author":"Suenari","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.jcin.2015.10.049_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcin.2012.08.018","article-title":"Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes","volume":"6","author":"Brener","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2015.10.049_bib14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jcin.2012.05.007","volume":"5","author":"Pride","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2015.10.049_bib15","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2015.10.049_bib16","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2015.10.049_bib17","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ahj.2004.04.036","article-title":"Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale","volume":"148","author":"Stone","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2015.10.049_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2008.02.008","article-title":"The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale","volume":"156","author":"Mehran","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2015.10.049_bib19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2015.10.049_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0735-1097(01)01779-X","article-title":"Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction","volume":"39","author":"Stone","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2015.10.049_bib21","first-page":"6B","article-title":"Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention","volume":"22","author":"Sianos","year":"2010","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jcin.2015.10.049_bib22","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/01.CIR.0000014683.52177.B5","article-title":"Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction","volume":"105","author":"Gibson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2015.10.049_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00019501-200605000-00010","article-title":"A\u00a0new approach of primary angioplasty for ST-elevation acute myocardial infarction based on minimalist immediate mechanical intervention","volume":"17","author":"Isaaz","year":"2006","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jcin.2015.10.049_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1540-8183.2010.00561.x","article-title":"No-reflow phenomenon following percutaneous coronary intervention for acute myocardial\u00a0infarction: incidence, outcome, and effect of pharmacologic therapy","volume":"23","author":"Rezkalla","year":"2010","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jcin.2015.10.049_bib25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s12013-013-9581-0","article-title":"Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction","volume":"67","author":"Fu","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.jcin.2015.10.049_bib26","first-page":"278","article-title":"Myocardial no-reflow treatment","volume":"11","author":"Muller","year":"2013","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jcin.2015.10.049_bib27","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/eurheartj\/ehs456","article-title":"Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study\u2013TROFI trial","volume":"34","author":"Onuma","year":"2013","journal-title":"Eur Heart J"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879815018907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879815018907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:02:05Z","timestamp":1761847325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879815018907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1936879815018907"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2015.10.049","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in\u00a0Acute Coronary Syndromes?","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2015.10.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}